Could a gentle brain zap help breast cancer survivors think clearly again?

NCT ID NCT02726763

Ongoing Symptom relief Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS), combined with cognitive training, is feasible and tolerable for breast cancer survivors who have memory or thinking problems after chemotherapy. The study will enroll 18 survivors aged 40-65 who completed treatment at least six months ago. The goal is to see if this approach is practical and well-tolerated, not yet to measure effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcranial direct current stimulation (tDCS) device
What this could lead to: If it works, this could point toward a non-drug way to help memory problems in breast cancer survivors after chemotherapy.
What could go wrong: This is a very small pilot study with only 18 people, so it can't prove effectiveness. It only checks if the approach is practical and tolerable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER SURVIVORS

Contacts and locations

Locations

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.